Schaeffer's Investment Research

Our weekly market outlook, straight to your inbox.

Get the Schaeffer’s edge every Monday.

LEARN MORE ABOUT SCHAEFFER'S MONDAY MORNING OUTLOOK >>

A New Era Of Investing...

Just Released: The Latest Episode of Our Market Mashup Podcast

Bernie Schaeffer's

EDITOR'S PICK

Vertical Debit Spread Nets Quintuple Profit in 4 Days

Taiwan Semiconductor stock had seen several holds at the key 200-day moving average

Todd Salamone's

Monday Morning Outlook

Long-Term Significance of Last Week's SPX Rally

Last week's rally means previous resistance is now potential support

Rocky White's

Indicator of the Week

Historic SPX Performance Amid Poor Market Breadth

Why underperformance could be ahead for Wall Street

Small-Caps, Dow Rally as VIX Touches 3-Year Lows

Tesla Stock Could Perform Particularly Well in June

Don't Gamble on Wynn Resorts Stock This Month

Stocks Still Muted as Oil Prices Move Higher

Stocks are struggling for direction, as investors continue to unpack this morning's U.S. trade deficit data, which missed analysts' estimates. The Dow Jones Industrial Average (DJI) is flat, while th ... Stocks are struggling for direction, as investors continue to unpack this morning's U.S. trade deficit data, which missed analysts' estimates. The Dow Jones Industrial Average (DJI) is flat, while the S&P 500 Index (SPX) and the Nasdaq Composite (IXIC) are pointed modestly below breakeven. Mean ... Keep Reading

Arrow pointing down, Stock price decreasing, Bearish stock price movement

Novocure Stock Extends Rout Amid Treatment Concerns

Novocure Ltd (NASDAQ:NVCR) is up 2% to trade at $46.08 this morning, amid concerns around the commercial use of its experimental device to treat a type of lung cancer, which extended overall survival ... Novocure Ltd (NASDAQ:NVCR) is up 2% to trade at $46.08 this morning, amid concerns around the commercial use of its experimental device to treat a type of lung cancer, which extended overall survival among patients in a late-stage study. Piper Sandler and Wedbush lowered their price targets to $62 a ... Keep Reading

Biotech Stock Falls on Late-Stage Study

FibroGen Inc (NASDAQ:FGEN) stock is sliding today, after the biotech company announced disappointing results from a late-stage trial of pamrevlumab, its experimental drug to treat patients with Duchen ... FibroGen Inc (NASDAQ:FGEN) stock is sliding today, after the biotech company announced disappointing results from a late-stage trial of pamrevlumab, its experimental drug to treat patients with Duchenne muscular dystrophy. At last glance, FGEN was down 9% to trade at $17.02. The stock's 80-day movi ... Keep Reading

Earnings expectations, Earnings report, EPS, Earnings Analysis, Earnings

Stitch Fix Eyes Best Day in Over 2 Years on Revenue Win

Stitch Fix Inc (NASDAQ:SFIX) stock is up 28.5% at $4.73 this morning, following better-than-expected fiscal third-quarter results. The subscription e-tailer reported revenue of $394.9 million, after f ... Stitch Fix Inc (NASDAQ:SFIX) stock is up 28.5% at $4.73 this morning, following better-than-expected fiscal third-quarter results. The subscription e-tailer reported revenue of $394.9 million, after focusing on "improving efficiencies, maintaining profitability and cash flow." Following the event, S ... Keep Reading

Schaeffer's has been the #1 Options Trade Alert Publisher in the world since 1981. We are proud to deliver professional-grade trading alerts to individual investors every day.

Schaeffer's market insights are regularly featured in...

Founded by Bernie Schaeffer, we provide stock news, options insights, and premium trading services to options traders

Get the Schaeffer’s edge every Monday.